InvestorsHub Logo
Followers 59
Posts 2025
Boards Moderated 1
Alias Born 05/07/2003

Re: A deleted message

Friday, 10/23/2009 12:13:08 PM

Friday, October 23, 2009 12:13:08 PM

Post# of 64411
On 9:00 am EDT, Wednesday August 26, 2009

PLANTATION, Fla.--(BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB: NPHC - News), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully completed a licensing agreement that grants XenaCare Holdings (OTCBB:XCHO - News) ongoing exclusive United States marketing and distribution rights for Cobroxin in return for meeting specific minimum performance requirements.